Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Discontinuation and Chronic Subdural Hematoma Risk
NCT01470040Phase 4Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Feb 2012
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in chronic subdural hematoma (CSDH), myocardial infarction (MI), Transient Ischemic Attack (TIA), thrombosis, embolism, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
aspirin
03
Conditions
chronic subdural hematoma (CSDH)myocardial infarction (MI)Transient Ischemic Attack (TIA)thrombosisembolism
Beyond the preview
Go deeper on NCT01470040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470040.